Cargando…

Efficacy and safety of surufatinib in the treatment of advanced solid tumors: a systematic evaluation and meta‑analysis

Previous retrospective studies have suggested that surufatinib is effective for treating advanced solid tumors; however, the efficacy and safety of this drug needs to be investigated further via high-quality evidence or randomized controlled trials. In the present study, a meta-analysis was carried...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Tianying, Cheng, Yonglang, Du, Yichao, Tan, Peng, Li, Tongxi, Chen, Yifan, Gao, Lin, Fu, Wenguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193379/ https://www.ncbi.nlm.nih.gov/pubmed/37216159 http://dx.doi.org/10.3892/ol.2023.13859

Ejemplares similares

Kaempferol From Penthorum chinense Pursh Attenuates Hepatic Ischemia/Reperfusion Injury by Suppressing Oxidative Stress and Inflammation Through Activation of the Nrf2/HO-1 Signaling Pathway
por: Chen, Yifan, et al.
Publicado: (2022)

Zyxin promotes hepatocellular carcinoma progression via the activation of AKT/mTOR signaling pathway
por: CAI, TIANYING, et al.
Publicado: (2023)

Transcriptomic Analysis Reveals Lactobacillus reuteri Alleviating Alcohol-Induced Liver Injury in Mice by Enhancing the Farnesoid X Receptor Signaling Pathway
por: Cheng, Yonglang, et al.
Publicado: (2022)

Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
por: Cao, Yanshuo, et al.
Publicado: (2022)

The efficacy of oxaliplatin, surufatinib, and camrelizumab on neuroendocrine carcinoma: a case report and literature review
por: Wang, Xianhua, et al.
Publicado: (2022)

Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs)
por: Xu, Jianming
Publicado: (2021)

Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
por: Liu, Zhongan, et al.
Publicado: (2023)

Treatment-related adverse events as predictive biomarkers of efficacy in patients with advanced neuroendocrine tumors treated with surufatinib: results from two phase III studies
por: Li, J., et al.
Publicado: (2022)

Surufatinib-induced renal thrombotic microangiopathy: first case report and review of literature
por: Zhu, Wenjiao, et al.
Publicado: (2023)

The Dietary Supplement γ-Oryzanol Attenuates Hepatic Ischemia Reperfusion Injury via Inhibiting Endoplasmic Reticulum Stress and HMGB1/NLRP3 Inflammasome
por: Du, Yichao, et al.
Publicado: (2021)

MMP25-AS1/hsa-miR-10a-5p/SERPINE1 axis as a novel prognostic biomarker associated with immune cell infiltration in KIRC
por: Tan, Peng, et al.
Publicado: (2021)

Risk factors for hypercoagulability after laparoscopic hepatic haemangioma resection
por: Mei, Mingqiang, et al.
Publicado: (2023)

The efficacy and safety of oncolytic viruses in the treatment of intermediate to advanced solid tumors: a systematic review and meta-analysis
por: Gao, Peng, et al.
Publicado: (2021)

Glycolysis-Related LINC02432/Hsa-miR-98–5p/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma
por: Tan, Peng, et al.
Publicado: (2022)

A dose escalation/expansion study evaluating dose, safety, and efficacy of the novel tyrosine kinase inhibitor surufatinib, which inhibits VEGFR 1, 2, & 3, FGFR 1, and CSF1R, in US patients with neuroendocrine tumors
por: Dasari, Arvind, et al.
Publicado: (2023)

The Efficacy and Safety of Apatinib in Refractory/Relapse Advanced Pediatric Solid Tumor: A Retrospective Study
por: Sun, Feifei, et al.
Publicado: (2020)

Safety and efficacy evaluation of pertuzumab in patients with solid tumors
por: Zhu, Chenjing, et al.
Publicado: (2017)

Efficacy and safety of envafolimab in the treatment of advanced dMMR/MSI‑H solid tumors: A single‑arm meta‑analysis
por: Fan, Shaoqing, et al.
Publicado: (2023)

Safety and efficacy of immune checkpoint inhibitors in advanced cancer patients with autoimmune disease: A meta-analysis
por: Cai, Qi, et al.
Publicado: (2022)

Studies on the Safety and Efficacy of Pyrotinib in the Treatment of HER2- Positive Advanced Solid Tumors Excluding Breast Cancer
por: Yin, Yuzhen, et al.
Publicado: (2020)

The efficacy and safety of tivantinib in the treatment of solid tumors: a systematic review and meta-analysis
por: Zhang, Hao, et al.
Publicado: (2017)

Effect of food on the pharmacokinetics of TAS‐102 and its efficacy and safety in patients with advanced solid tumors
por: Yoshino, Takayuki, et al.
Publicado: (2016)

The Efficacy and Safety of PD-1/PD-L1 Inhibitors in Combination with Conventional Therapies for Advanced Solid Tumors: A Meta-Analysis
por: Nie, Run-Cong, et al.
Publicado: (2020)

Safety and efficacy of the pan-FGFR inhibitor erdafitinib in advanced urothelial carcinoma and other solid tumors: A systematic review and meta-analysis
por: Zheng, Xinyi, et al.
Publicado: (2023)

Efficacy and safety of nab-paclitaxel plus platinum in non-small cell lung cancer: a meta-analysis
por: Tan, Tianying, et al.
Publicado: (2023)

Exposure‐safety and exposure‐efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors
por: Passey, Chaitali, et al.
Publicado: (2023)

Clinical benefit and safety associated with mRNA vaccines for advanced solid tumors: A meta‐analysis
por: Zhang, Tian‐yi, et al.
Publicado: (2023)

Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis
por: Chen, Wen, et al.
Publicado: (2023)

Aloin Preconditioning Attenuates Hepatic Ischemia/Reperfusion Injury via Inhibiting TLR4/MyD88/NF-κB Signal Pathway In Vivo and In Vitro
por: Du, Yichao, et al.
Publicado: (2019)

Safety and efficacy of durvalumab (MEDI4736) in various solid tumors
por: Yang, Hui, et al.
Publicado: (2018)

Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors
por: Chen, Qiuqiang, et al.
Publicado: (2022)

Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid Tumors
por: Wang, Jianzheng, et al.
Publicado: (2022)

Efficacy and Safety of Scalp Acupuncture for Insomnia: A Systematic Review and Meta-Analysis
por: Liu, Fu-gui, et al.
Publicado: (2021)

Efficacy and safety of pediatric massage in the treatment of anorexia: A protocol for systematic review and meta-analysis
por: Yi, Baoxiu, et al.
Publicado: (2021)

Upregulated N‐cadherin expression is associated with poor prognosis in epithelial‐derived solid tumours: A meta‐analysis
por: Luo, Yong, et al.
Publicado: (2018)

A review of the safety and efficacy of current COVID-19 vaccines
por: Huang, Zehong, et al.
Publicado: (2022)

Effectiveness and safety of pelareorep plus chemotherapy versus chemotherapy alone for advanced solid tumors: a meta-analysis
por: Xie, Renxian, et al.
Publicado: (2023)

Tolerability and efficacy of durvalumab in Japanese patients with advanced solid tumors
por: Fujiwara, Yutaka, et al.
Publicado: (2019)

The efficacy and safety of immunotherapy in patients with advanced NSCLC: a systematic review and meta-analysis
por: Zhou, Liang, et al.
Publicado: (2016)

Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors
por: Ponomarenko, Dmitry M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2dhtpgpr4amr0vv6g36ofrjdfj